Costs of detecting and treating cancer of the uterine cervix in North-East Scotland in 1971.
In 1971 the Aberdeen cytology service handled 22,291 cervical smears--threequarters from women participating in a screening programme and the rest from women with symptoms who were referred to hospital.  As a result of screening, 56 preclinical cases of cancer of the cervix uteri were treated in hospital; 13 others were classified as less than preclinical.  Of the gynaecological patients 20 had clinical cancer and 29 had less than preclinical lesions.  From estimates of the costs of running the cytology service and of hospital inpatient costs it is possible to derive figures for detecting and treating preclinical cases and investigating and treating clinical cases.  The cost to the Health Service of detecting and treating each preclinical case was slightly less (445 pounds) than that for impatient treatment of each clinical case (487 pounds).  However, if mass screening were abandoned cytology would almost certainly continue for women referred to hospital with symptoms, and, if the costs of taking and examining these smears is taken into account, the cost per clinical case treated nearly doubles to 835 pounds.  Had outpatient and other follow-up costs been included, the difference in service costs would be even greater.  Comparison of these figures assumes the controversial point that preclinical cancer will always progress to invasive carcinoma if left untreated and takes no account of inflation and discounting.
D002278:Carcinoma in Situ / Q000175:diagnosis* / Q000601:surgery / Q000628:therapy; D003365:Costs and Cost Analysis; D004469:Economics, Hospital; D005260:Female; D006801:Humans; D007044:Hysterectomy; D007902:Length of Stay; D008403:Mass Screening; D010044:Outpatient Clinics, Hospital; D011230:Precancerous Conditions / Q000175:diagnosis / Q000628:therapy; D012606:Scotland; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000601:surgery / Q000628:therapy; D014626:Vaginal Smears